[Hepadigest (UR-232) clinical experimentation].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D002763:Cholecystectomy; D003005:Clopamide / Q000627:therapeutic use; D003503:Cyclobutanes / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D005990:Glycerol / Q000627:therapeutic use; D006801:Humans; D007773:Lactates / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy; D011343:Procaine / Q000627:therapeutic use; D014149:Tranquilizing Agents
D003503:Cyclobutanes; D007773:Lactates; D014149:Tranquilizing Agents; D003005:Clopamide; D011343:Procaine; D005990:Glycerol
Hepadigest (UR-232). Experimentación clínica.